Is Labcorp Holdings Inc. (LH) a Buy, Sell, or Hold?
NYSE : LH
Labcorp Holdings Inc. — Insider Trades
$281.48 USD
-$1.88 (-0.66%)
- Volume
- 520.24K
- Average Volume
- 660.53K
- Market Capitalization
- $23.08B
- P/E Ratio
- 24.76
- Dividend Yield
- 1.02%
- Price Target
- $300.00
- Year High
- $293.72
- Year Low
- $244.52
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.26
- Current Ratio
- $1.73
Insider Activity Summary (Last 12 Months)
Insiders Buying
99
Insiders Selling
132
Amount of Insider Selling
$147.43K
LH Insider Buying/Selling by Quarter
LH Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Kyle Kathryn W | officer: EVP, Chief Legal Officer | 2026-07-01 | M-Exempt | 0 | 2026-07-06 |
| Kyle Kathryn W | officer: EVP, Chief Legal Officer | 2026-07-01 | F-InKind | 283.88 | 2026-07-06 |
| Kyle Kathryn W | officer: EVP, Chief Legal Officer | 2026-07-02 | S-Sale | 286.19 | 2026-07-06 |
| Kyle Kathryn W | officer: EVP, Chief Legal Officer | 2026-07-01 | M-Exempt | 0 | 2026-07-06 |
| Vaughn Bryan T | officer: EVP and President, Diagnostics | 2026-07-01 | M-Exempt | 0 | 2026-07-06 |
| Vaughn Bryan T | officer: EVP and President, Diagnostics | 2026-07-01 | F-InKind | 283.88 | 2026-07-06 |
| Vaughn Bryan T | officer: EVP and President, Diagnostics | 2026-07-02 | S-Sale | 286.19 | 2026-07-06 |
| Vaughn Bryan T | officer: EVP and President, Diagnostics | 2026-07-01 | M-Exempt | 0 | 2026-07-06 |
| Kyle Kathryn W | officer: EVP, Chief Legal Officer | 2026-06-08 | S-Sale | 263.89 | 2026-06-10 |
| Schechter Adam H | director, officer: President & CEO | 2026-05-11 | S-Sale | 254.5 | 2026-05-13 |
| Schechter Adam H | director, officer: President & CEO | 2026-03-26 | A-Award | 0 | 2026-03-30 |
| Schechter Adam H | director, officer: President & CEO | 2026-03-26 | F-InKind | 268.38 | 2026-03-30 |
| GRAHAM ANITA Z | officer: EVP, CHRO | 2026-03-26 | A-Award | 0 | 2026-03-30 |
| GRAHAM ANITA Z | officer: EVP, CHRO | 2026-03-26 | F-InKind | 268.38 | 2026-03-30 |
| Schroeder Mark S | officer: EVP, Pres Diagnostics & COO | 2026-03-26 | A-Award | 0 | 2026-03-30 |
| Schroeder Mark S | officer: EVP, Pres Diagnostics & COO | 2026-03-26 | A-Award | 0 | 2026-03-30 |
| Schroeder Mark S | officer: EVP, Pres Diagnostics & COO | 2026-03-26 | F-InKind | 268.38 | 2026-03-30 |
| Schroeder Mark S | officer: EVP, Pres Diagnostics & COO | 2026-03-26 | F-InKind | 268.38 | 2026-03-30 |
| Caveney Brian J | officer: EVP, Pres of ED, CMO & CSO | 2026-03-26 | A-Award | 0 | 2026-03-30 |
| Caveney Brian J | officer: EVP, Pres of ED, CMO & CSO | 2026-03-26 | A-Award | 0 | 2026-03-30 |
| Caveney Brian J | officer: EVP, Pres of ED, CMO & CSO | 2026-03-26 | F-InKind | 268.38 | 2026-03-30 |
| Caveney Brian J | officer: EVP, Pres of ED, CMO & CSO | 2026-03-26 | F-InKind | 268.38 | 2026-03-30 |
| Wilkinson Peter J | officer: SVP, Chief Accounting Officer | 2026-03-26 | A-Award | 0 | 2026-03-30 |
| Wilkinson Peter J | officer: SVP, Chief Accounting Officer | 2026-03-26 | F-InKind | 268.38 | 2026-03-30 |
| Wilkinson Peter J | officer: SVP, Chief Accounting Officer | 2026-03-27 | S-Sale | 267.05 | 2026-03-30 |
| Vaughn Bryan T | officer: EVP, Diagnostics | 2026-03-26 | A-Award | 0 | 2026-03-30 |
| Vaughn Bryan T | officer: EVP, Diagnostics | 2026-03-26 | F-InKind | 268.38 | 2026-03-30 |
| van der Vaart Sandra D | officer: EVP, Corporate Affairs | 2026-03-26 | A-Award | 0 | 2026-03-30 |
| van der Vaart Sandra D | officer: EVP, Corporate Affairs | 2026-03-26 | F-InKind | 268.38 | 2026-03-30 |
| Summy Amy B. | officer: EVP, Chief Marketing Officer | 2026-03-26 | A-Award | 0 | 2026-03-30 |
| Summy Amy B. | officer: EVP, Chief Marketing Officer | 2026-03-26 | F-InKind | 268.38 | 2026-03-30 |
| Oyegunwa Akinbolade | officer: EVP, CIO & CTO | 2026-03-26 | A-Award | 0 | 2026-03-30 |
| Oyegunwa Akinbolade | officer: EVP, CIO & CTO | 2026-03-26 | F-InKind | 268.38 | 2026-03-30 |
| Meltzer Jonathan C | officer: EVP, Operations | 2026-03-26 | A-Award | 0 | 2026-03-30 |
| Meltzer Jonathan C | officer: EVP, Operations | 2026-03-26 | F-InKind | 268.38 | 2026-03-30 |
| Meltzer Jonathan C | officer: EVP, Operations | 2026-03-27 | S-Sale | 267.05 | 2026-03-30 |
| Kyle Kathryn W | officer: EVP, Chief Legal Officer | 2026-03-26 | A-Award | 0 | 2026-03-30 |
| Kyle Kathryn W | officer: EVP, Chief Legal Officer | 2026-03-26 | F-InKind | 268.38 | 2026-03-30 |
| Bailey Megan D. | officer: EVP, Pres, Central Labs & Intl | 2026-03-26 | A-Award | 0 | 2026-03-30 |
| Bailey Megan D. | officer: EVP, Pres, Central Labs & Intl | 2026-03-26 | F-InKind | 268.38 | 2026-03-30 |
| Schechter Adam H | director, officer: President & CEO | 2026-03-03 | S-Sale | 279.9595 | 2026-03-05 |
| van der Vaart Sandra D | officer: EVP, Corporate Affairs | 2026-02-27 | S-Sale | 284.91 | 2026-03-03 |
| Caveney Brian J | officer: EVP, Pres of ED, CMO & CSO | 2026-02-24 | S-Sale | 286.305 | 2026-02-26 |
| Wilkinson Peter J | officer: SVP, Chief Accounting Officer | 2026-02-19 | S-Sale | 277.94 | 2026-02-23 |
| Summy Amy B. | officer: EVP, Chief Marketing Officer | 2026-02-11 | M-Exempt | 0 | 2026-02-13 |
| Summy Amy B. | officer: EVP, Chief Marketing Officer | 2026-02-11 | F-InKind | 289.89 | 2026-02-13 |
| Summy Amy B. | officer: EVP, Chief Marketing Officer | 2026-02-11 | M-Exempt | 0 | 2026-02-13 |
| Wilkinson Peter J | officer: SVP, Chief Accounting Officer | 2026-02-11 | M-Exempt | 0 | 2026-02-13 |
| Wilkinson Peter J | officer: SVP, Chief Accounting Officer | 2026-02-11 | F-InKind | 289.89 | 2026-02-13 |
| Wilkinson Peter J | officer: SVP, Chief Accounting Officer | 2026-02-11 | F-InKind | 289.89 | 2026-02-13 |
| Wilkinson Peter J | officer: SVP, Chief Accounting Officer | 2026-02-11 | M-Exempt | 0 | 2026-02-13 |
| Wilkinson Peter J | officer: SVP, Chief Accounting Officer | 2026-02-11 | M-Exempt | 0 | 2026-02-13 |
| Wang Julia Aijun | officer: Chief Financial Officer, EVP | 2026-02-11 | M-Exempt | 0 | 2026-02-13 |
| Wang Julia Aijun | officer: Chief Financial Officer, EVP | 2026-02-11 | M-Exempt | 0 | 2026-02-13 |
| Wang Julia Aijun | officer: Chief Financial Officer, EVP | 2026-02-11 | F-InKind | 289.89 | 2026-02-13 |
| Vaughn Bryan T | officer: EVP, Diagnostics | 2026-02-11 | M-Exempt | 0 | 2026-02-13 |
| Vaughn Bryan T | officer: EVP, Diagnostics | 2026-02-11 | F-InKind | 289.89 | 2026-02-13 |
| Vaughn Bryan T | officer: EVP, Diagnostics | 2026-02-11 | M-Exempt | 0 | 2026-02-13 |
| van der Vaart Sandra D | officer: EVP, Corporate Affairs | 2026-02-11 | M-Exempt | 0 | 2026-02-13 |
| van der Vaart Sandra D | officer: EVP, Corporate Affairs | 2026-02-11 | F-InKind | 289.89 | 2026-02-13 |
| van der Vaart Sandra D | officer: EVP, Corporate Affairs | 2026-02-11 | M-Exempt | 0 | 2026-02-13 |
| Schroeder Mark S | officer: EVP, Pres Diagnostics & COO | 2026-02-11 | M-Exempt | 0 | 2026-02-13 |
| Schroeder Mark S | officer: EVP, Pres Diagnostics & COO | 2026-02-11 | F-InKind | 289.89 | 2026-02-13 |
| Schroeder Mark S | officer: EVP, Pres Diagnostics & COO | 2026-02-11 | M-Exempt | 0 | 2026-02-13 |
| Schechter Adam H | director, officer: President & CEO | 2026-02-11 | M-Exempt | 0 | 2026-02-13 |
| Schechter Adam H | director, officer: President & CEO | 2026-02-11 | F-InKind | 289.89 | 2026-02-13 |
| Schechter Adam H | director, officer: President & CEO | 2026-02-11 | S-Sale | 284.38 | 2026-02-13 |
| Schechter Adam H | director, officer: President & CEO | 2026-02-11 | M-Exempt | 0 | 2026-02-13 |
| Oyegunwa Akinbolade | officer: EVP, CIO & CTO | 2026-02-11 | M-Exempt | 0 | 2026-02-13 |
| Oyegunwa Akinbolade | officer: EVP, CIO & CTO | 2026-02-11 | F-InKind | 289.89 | 2026-02-13 |
| Oyegunwa Akinbolade | officer: EVP, CIO & CTO | 2026-02-11 | M-Exempt | 0 | 2026-02-13 |
| Meltzer Jonathan C | officer: EVP, Operations | 2026-02-11 | M-Exempt | 0 | 2026-02-13 |
| Meltzer Jonathan C | officer: EVP, Operations | 2026-02-11 | F-InKind | 289.89 | 2026-02-13 |
| Meltzer Jonathan C | officer: EVP, Operations | 2026-02-12 | S-Sale | 290.42 | 2026-02-13 |
| Meltzer Jonathan C | officer: EVP, Operations | 2026-02-11 | M-Exempt | 0 | 2026-02-13 |
| Kyle Kathryn W | officer: EVP, Chief Legal Officer | 2026-02-11 | M-Exempt | 0 | 2026-02-13 |
| Kyle Kathryn W | officer: EVP, Chief Legal Officer | 2026-02-11 | F-InKind | 289.89 | 2026-02-13 |
| Kyle Kathryn W | officer: EVP, Chief Legal Officer | 2026-02-11 | M-Exempt | 0 | 2026-02-13 |
| GRAHAM ANITA Z | officer: EVP, CHRO | 2026-02-11 | M-Exempt | 0 | 2026-02-13 |
| GRAHAM ANITA Z | officer: EVP, CHRO | 2026-02-11 | M-Exempt | 0 | 2026-02-13 |
| GRAHAM ANITA Z | officer: EVP, CHRO | 2026-02-11 | F-InKind | 289.89 | 2026-02-13 |
| Caveney Brian J | officer: EVP, Pres of ED, CMO & CSO | 2026-02-11 | M-Exempt | 0 | 2026-02-13 |
| Caveney Brian J | officer: EVP, Pres of ED, CMO & CSO | 2026-02-11 | F-InKind | 289.89 | 2026-02-13 |
| Caveney Brian J | officer: EVP, Pres of ED, CMO & CSO | 2026-02-11 | M-Exempt | 0 | 2026-02-13 |
| Bailey Megan D. | officer: EVP, Pres, Central Labs & Intl | 2026-02-11 | M-Exempt | 0 | 2026-02-13 |
| Bailey Megan D. | officer: EVP, Pres, Central Labs & Intl | 2026-02-11 | F-InKind | 289.89 | 2026-02-13 |
| Bailey Megan D. | officer: EVP, Pres, Central Labs & Intl | 2026-02-11 | M-Exempt | 0 | 2026-02-13 |
| Rothman Paul | director | 2026-02-11 | M-Exempt | 0 | 2026-02-13 |
| Rothman Paul | director | 2026-02-11 | M-Exempt | 0 | 2026-02-13 |
| Wengel Kathryn E | director | 2026-02-11 | M-Exempt | 0 | 2026-02-13 |
| Wengel Kathryn E | director | 2026-02-11 | M-Exempt | 0 | 2026-02-13 |
| Parham Richelle P | director | 2026-02-11 | M-Exempt | 0 | 2026-02-13 |
| Parham Richelle P | director | 2026-02-11 | M-Exempt | 0 | 2026-02-13 |
| NEUPERT PETER M | director | 2026-02-11 | M-Exempt | 0 | 2026-02-13 |
| NEUPERT PETER M | director | 2026-02-11 | M-Exempt | 0 | 2026-02-13 |
| Kong Garheng | director | 2026-02-11 | M-Exempt | 0 | 2026-02-13 |
| Kong Garheng | director | 2026-02-11 | M-Exempt | 0 | 2026-02-13 |
| Kliphouse Kirsten Marie | director | 2026-02-11 | M-Exempt | 0 | 2026-02-13 |
| Kliphouse Kirsten Marie | director | 2026-02-11 | M-Exempt | 0 | 2026-02-13 |
| Davis Jeffrey A. | director | 2026-02-11 | M-Exempt | 0 | 2026-02-13 |